Skip to main content
. 2020 Jun;9(3):676–688. doi: 10.21037/gs.2020.04.06

Table 1. Patient characteristics.

Age (years) Histopathology type Previous abdominal surgeries Breast reconstruction type Mammary sample size (cm) Abdominal incisions Operating time/omental flap harvesting time (mins) Blood loss (mL) Drainage volume (mL) Drainage tube withdrawn time (days) Hospital stay (days) Local recurrence or distant metastasis Following-up time (months)
1 33 Poorly differentiated invasive ductal carcinoma ESM + LHPOF 11×7.5×1–2 3 283/32 50 56 4 15 27.7
2 53 Moderately differentiated invasive ductal carcinoma ESM + LHPOF + prosthetic implant 13×12×3 3 495/82 10 65 17 24 27.3
3 58 Mammary ductal carcinoma in situ Appendectomy ESM + LHPOF 13×11×2 3 150/38 50 264 6 13 25.3
4 34 Invasive ductal carcinoma ESM + LHPOF 12×10×1.5 4 394/95 20 66 9 20 23.8
5 60 Invasive ductal carcinoma ESM + LHPOF 12×11×2 3 360/62 50 370 15 17 23.7
6 41 Invasive ductal carcinoma ESM + LHPOF + prosthetic implant 17×18×3 3 476/92 10 395 9 16 22.9
7 58 Invasive ductal carcinoma (50%), invasive lobular carcinoma (50%) hysterectomy and bilateral adnexectomy ESM + LHPOF 15×14×1.5 4 370/50 30 336 8 20 19.6
8 61 Invasive ductal carcinoma ESM + LHPOF 12×10×2 4 289/52 50 63 6 14 19.3
9 43 Invasive ductal carcinoma Hysterectomy ESM + LHPOF + prosthetic implant 14×11×3 3 405/68 50 240 7 8 15.8
10 45 Ductal carcinoma in situ ESM + LHPOF 11×10×1 4 355/58 50 65 4 6 14.5